Table 2.
Subject characteristics | COPD
|
Smokers
|
Never-smokers
|
|||
---|---|---|---|---|---|---|
r-value | P-value | r-value | P-value | r-value | P-value | |
Age, years | 0.421 | <0.001 | 0.408 | 0.074 | 0.468 | 0.037 |
Body mass index, m/kg2 | 0.131 | 0.321 | −0.235 | 0.319 | 0.108 | 0.650 |
Smoking history, pack-years | 0.046 | 0.732 | 0.331 | 0.154 | ||
Systolic blood pressure, mmHg | 0.314 | 0.016 | −0.101 | 0.672 | 0.224 | 0.357 |
Acute exacerbation rate, n/year | 0.251 | 0.014 | ||||
FEV1, % predicted | −0.185 | 0.160 | 0.303 | 0.194 | 0.181 | 0.445 |
FVC, % predicted | 0.034 | 0.799 | 0.355 | 0.125 | 0.094 | 0.693 |
FEV1/FVC ratio | −0.286 | 0.028 | 0.115 | 0.631 | −0.280 | 0.231 |
HbA1c, % | 0.180 | 0.188 | 0.058 | 0.808 | 0.329 | 0.156 |
HDL/LDL ratio | 0.047 | 0.69 | 0.376 | 0.151 | 0.440 | 0.115 |
Neutrophil count, ×103/mL | −0.056 | 0.681 | 0.018 | 0.943 | 0.278 | 0.235 |
Ln interleukin-6, pg/mL | 0.365 | 0.006 | 0.229 | 0.346 | −0.229 | 0.331 |
Ln pro-BNP, pg/mL | 0.225 | 0.101 | 0.185 | 0.477 | 0.338 | 0.169 |
Ln ADMA, μmol/L | 0.331 | 0.013 | 0.048 | 0.840 | −0.283 | 0.226 |
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Ln, natural logarithm; Pro-BNP, pro b-type natriuretic peptide; ADMA, asymmetric dimethylarginine.